NZ start-up's ginger-based rheumatoid arthritis therapy in clinical trials

NZ start-up's ginger-based rheumatoid arthritis therapy in clinical trials
Evithé Biotechnology founder Cynthia Hunefeld. (Image: Supplied)
Greg Hurrell
A New Zealand start-up is carrying out phase one clinical trials of its rheumatoid arthritis therapy based on the ginger plant.Evithé Biotechnology is a spinout company from Victoria University developing botanical and multi-target pharmaceutical prescription drugs from ginger rhizomes.Beyond rheumatoid arthritis, the company has a pipeline of botanical and pharmaceutical prescription drugs that could get to the root of other inflammatory disorders such as Alzheimer’s disease and sepsis.It hopes to have its first therapies on the m...

More Editor's Picks

Future of apprenticeships kicked down the road again
Property

Future of apprenticeships kicked down the road again

Industries will be presented with two options this month, the skills minister says.

Maria Slade 14 Jan 2025
Beyond the glitter: Can gold hedge against a falling NZ dollar?
Markets

Beyond the glitter: Can gold hedge against a falling NZ dollar?

Gold gained 42% in NZ dollar terms last year, its value helped by falling interest rates.

Rebecca Howard 13 Jan 2025
Health New Zealand seeks chief executive
Editor's Picks

Health New Zealand seeks chief executive

The under-fire agency is launching a global search. The existing CEO can also reapply.

Oliver Lewis 10 Jan 2025
Why James Miller is joining Fletcher’s board
Markets

Why James Miller is joining Fletcher’s board

James Miller says directors need to step up when companies face difficulties.